OrbiMed’s St Jude Medical STJ Stock Holding History

OrbiMed’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-125,000	Closed	-$8.66M	–	150
2014 Q2	$8.66M	Buy	+125,000	New	+$8.1M	0.1%	93

Other funds holding STJ

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

OrbiMed's STJ Position: Q1 2015 in Review

OrbiMed sold out of St Jude Medical (STJ) in Q1 2015, closing a stake of 173,000 shares — an estimated $11.3M sold.

OrbiMed first reported a position in STJ in Q2 2013 and held it in 7 quarters. The position peaked at $115M in Q2 2014. 590 funds tracked by Wall St. Rank hold STJ as of Q1 2015.

OrbiMed reported no remaining St Jude Medical position as of Q1 2015 after selling out during the quarter.
OrbiMed sold 173,000 St Jude Medical shares in Q1 2015, an estimated $11.3M.
OrbiMed first reported a position in St Jude Medical in Q2 2013 and held it in 7 quarters.
OrbiMed's St Jude Medical position peaked at $115M in Q2 2014.
590 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2015.

Based on OrbiMed's 13F filing for Q1 2015, filed 15 May 2015.